JLE

European Journal of Dermatology

MENU

Pemphigus and depression comorbidity: a case control study Volume 25, numéro 6, November-December 2015

Auteurs
1 Dermatology Service,
Barzilai University Medical Center,
Ashkelon 78278 Israel
2 Faculty of Health Sciences,
Ben-Gurion University of the Negev,
Beer-Sheva, Israel
3 Pediatric Dermatology Unit,
Department of Dermatology,
Tel Aviv Sourasky Medical Center,
6 Weizmann Street, Tel Aviv 64239, Israel
4 Department of Dermatology;
Centre national de référence des maladies génétiques à expression cutanée (Magec),
hôpital universitaire Necker-Enfants Malades;
APHP; université Paris Descartes - Sorbonne Paris Cité;
Institut Imagine,
Paris, France
5 Siaal Research Center for Family Medicine and Primary Care,
Ben -Gurion University of the Negev,
Beer-Sheva, Israel
6 Research and Health Planning Department,
Clalit Health Services,
Tel Aviv 6209804 Israel
* Reprints
a These authors contributed equally to the paper.

Pemphigus is a relatively rare but severe autoimmune bullous disease, involving the skin and mucous membranes. The most common forms are pemphigus vulgaris (PV) and pemphigus foliaceus (PF). The overall incidence of the disease, which carries substantial morbidity and is potentially fatal, varies from 0.75 to 5 cases per million per year [1]. Pemphigus patients experience a decrease in quality of life (QOL) affecting physical, psychological and social aspects. While anxiety and depression have been [...]